Phase II Randomized Double-Blind Evaluation of Two Dose Levels of LY353381 Hydrochloride Administered to Women With Locally Advanced or Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Arzoxifene (Primary)
- Indications Advanced breast cancer; Breast cancer
- Focus Therapeutic Use
- 17 Dec 2009 Planned number of patients changed from 104 to 114 as reported by ClinicalTrials.gov.
- 15 Oct 2005 New trial record.